Table 1.
Metformin | Sulphonylureas | SGLT-2 Inhibitors | DPP-4 Inhibitors | GLP-1 Agonists | Thiazolidinediones | Insulin |
---|---|---|---|---|---|---|
↓ intestinal glucose absorption | ↑ insulin release by pancreatic B-cells | ↑ urinary glucose excretion | ↑ endogenous incretin concentration of GLP-1 and GIP | ↑ GLP-1 receptor activation | ↑ uptake of free fatty acids by adipocytes | ↑ glucose utilization and storage by increasing glucose transport and net glycogen synthesis |
↑ glucose utilization by intestinal cells | ↑ tissue sensitivity to insulin | ↑ glucose utilization | ↑ sensitivity of pancreatic B-cells to glucose and ↑ glucose dependent insulin secretion | ↓ glucagon secretion in a-cells | ↑ secretion of adiponectin | ↑ glucose transport into cells and net glycogen synthesis |
↓ hepatic gluconeogenesis and glycogenolysis | ↑ glucose transport into adipose tissue and muscles | ↓ insulin resistance | ↑ sensitivity of a-cells to glucose, glucagon secretion | ↑ glucose-dependent insulin secretion | ↓ production of TNF-a | white adipose tissue (WAT): ↓ lipolysis, ↑ glucose transport, ↑ lipogenesis |
↑ glucose uptake and utilization by peripheral tissues | ↑ glycogenesis in liver and muscles | ↓ glucotoxicity | ↓ hepatic glucose secretion both in fasting and postprandial states | ↓ B-cell death, ↑B-cell proliferation, ↑ expansion of B-cell mass | ↓ production of resistin | Liver: ↑ activation of glycogen synthesis, ↑ lipogenic gene expression, ↓ gluconeogenic gene expression |
↑ peripheral insulin sensitivity | ↓ synthesis of glucose and oxidation of fatty acids in the liver | adipose tissue: ↑ lipolysis, fatty acid oxidation and ketone body formation, ↓ visceral and epicardial fat mass | delay in gastric emptying, ↓ caloric intake and weight loss | ↓ islet inflammation | ↑ HDL-cholesterol concentration | Muscle cells: ↑ glycogenesis and ↓ protein synthesis, protein catabolism |
↑ fatty acid oxidation in adipose tissue and skeletal muscles | Hepatic: ↑ gluconeogenesis, ↑ ketogenesis, ↑ hepatic glucose output, ↓ hepatic steatosis | ↑ delayed gastric emptying, ↓ food intake, ↑ weight loss | ↑ LDL-cholesterol concentration and particle size | Pancreatic beta cells: ↓ glucagon release | ||
↑ lipolysis and inhibits lipogenesis | Cardiovascular: ↓ intravascular volume, ↓ blood pressure, ↓ cardiac preload and afterload, improves endothelial and ↓ vascular stiffness | ↓ triglyceride concentration | ||||
↓ the nuclear factor KB pathway in immune cells | ↓ plasminogen activator inhibitor-1 and fibrinogen | |||||
↓ the differentiation of monocytes to macrophages | anti-inflammatory effects | |||||
↓ inflammation |